Prot# CG53135-CLN-12: A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant

Project: Research project

Project Details

StatusFinished
Effective start/end date8/25/063/1/12

Funding

  • PPD Development (CG53135-CLN-12)
  • CuraGen Corporation (CG53135-CLN-12)